Drug Approval | May 30, 2026
Lupin secures FDA nod for generic Sutab tablets with 180-day exclusivity
The approved product is the generic equivalent of Sutab® Tablets developed by Azurity Pharmaceuticals
The approved product is the generic equivalent of Sutab® Tablets developed by Azurity Pharmaceuticals
Strong domestic and international growth, improving product mix, and operational efficiencies drive margin expansion despite exceptional charges impacting quarterly profit
The ruling comes against the backdrop of a mounting trauma burden in India, where nearly 4.67 lakh accidental deaths occur annually
First-in-human study of investigational SOS1 inhibitor shows encouraging safety profile and early anti-tumor activity in patients with metastatic solid tumors
Libre Duo devices become the first glucose-ketone monitors approved for diabetes care, offering real-time alerts for diabetic ketoacidosis risk
From import dependence to global leadership, the next phase of growth must be driven not only by manufacturing scale and policy support, but also by innovation, research, and globally competitive healthcare technologies
The syrup launched by company's Chezgreen division is designed to provide supportive care in managing common menstrual concerns such as amenorrhea, dysmenorrhea, and menorrhagia
Hikal’s Q4 profit remained sharply lower year-on-year, falling 71% from Rs. 50.2 crore in Q4 FY25 as the company absorbed regulatory pressures and strategic accounting adjustments
Under the new initiative, each company takes on a defined role across the recycling chain
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
